HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

CMDBS 25

a synthetic substituted dextran polymer; has 73% carboxylic groups and 15% benzylamide sulfonate groups
Also Known As:
CMDB7; CMDBJ cpd; CMDBS; CMDBS-1; CMDBS-2; CMDBS-25; CMDBS25; carboxy methyl dextran benzylamide jorge; carboxymethylbenzylamide sulfonate dextran CMDBS25
Networked: 10 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Hamma-Kourbali, Y: 3 articles (07/2003 - 06/2001)
2. Crépin, M: 3 articles (07/2003 - 06/2001)
3. Bagheri-Yarmand, R: 3 articles (10/2001 - 01/2001)
4. Perret, G: 2 articles (07/2003 - 10/2001)
5. Vassy, R: 2 articles (07/2003 - 10/2001)
6. Starzec, A: 2 articles (07/2003 - 10/2001)
7. Martin, A: 1 article (07/2003)
8. Kraemer, M: 1 article (07/2003)
9. Oudar, O: 1 article (10/2001)
10. Le Meuth-Metzinger, V: 1 article (10/2001)

Related Diseases

1. Neoplasms (Cancer)
2. Corneal Ulcer
3. Squamous Cell Carcinoma (Epidermoid Carcinoma)
4. Neoplasm Metastasis (Metastasis)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
2. Tamoxifen
3. Epidermal Growth Factor (EGF)
4. Heparin (Liquaemin)
5. Dextrans (Dextran)
6. Intercellular Signaling Peptides and Proteins (Growth Factors)
7. Platelet-Derived Growth Factor
8. carboxymethyl dextran
9. Neutralizing Antibodies
10. Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)